Industries > Pharma > Cell-Based Assays World Industry and Market 2018-2028

Cell-Based Assays World Industry and Market 2018-2028

Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs

PUBLISHED: 18 September 2018
PAGES: 241
PRODUCT CODE: PHA0331
SUBMARKET: Diagnostics

Clear
WOOCS 2.2.1
SKU: PHA0331 Categories: , Tags: ,

The revenue of the cell-based assays market in 2017 is estimated at $13bn and is expected to grow at a CAGR of 9.2% in the first half of the forecast period. Visiongain estimated that the consumables and services segments accounted for 74.26% of the market.

How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.

In this brand new 241-page report you will receive 85 tables and 103 figures– all unavailable elsewhere.

The 241-page report provides clear detailed insight into the cell-based assays market. Discover the key drivers and challenges affecting the market.

By ordering and reading our brand-new report today you stay better informed and ready to act.

Report Scope

Cell-based Assays market forecasts from 2018-2028

• Cell-Based Assays Market by Product Type:
• Instrument
• Consumables
• Software
• Services
• Reagents
• Assay Kits
• Microplates
• Cell Lines
• Probes & Labels

• Cell-Based Assays Market by Application:
• Drug Discovery
• Basic Research
• Predictive Technology

• Cell-based Assays Market by End-User:
• Pharma & Biotech Companies
• Academic Institutes
• CROs

• This report provides individual revenue forecasts to 2028 for these national markets:
• US
• Japan
• Germany
• UK
• France
• Spain
• Italy
• China
• India
• Russia
• Brazil

• Our study includes SWOT and STEP analysis of the cell-based assays market.

• Our study discusses the selected leading companies that are the major players in the cell-based assays market:
• BD (Becton, Dickinson and Company)
• BioAgilytix Labs
• BioVision
• Cell Assay Innovations, Inc.
• Charles River Laboratories International
• CYTOO SA
• DiscoverX
• GE Healthcare
• InSphero
• Marin Biological Laboratories
• Molecular Devices
• Perkin Elmer
• Pharmaceutical Product Development
• Porsolt
• Promega
• ProQinase GmbH
• QGel
• SGS Group, Inc.
• Thermo Fisher Scientific (and Affymetrix acquisition)

Cell-Based Assays World Industry and Market 2018-2028

• This report also discusses technology, trends and future outlook of the cell-based assays industry

Visiongain’s study is intended for anyone requiring commercial analyses for the cell-based assays market. You find data, trends and predictions.

Buy our report today Cell-Based Assays World Industry and Market 2018-2028: Drug Discovery, Basic Research, Predictive Technology, Instrument, Consumables, Software, Services, Reagents, Assay Kits, Microplates, Cell Lines, Probes & Labels, Pharma & Biotech Companies, Academic Institutes, CROs.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Cell-Based Assays World Industry and Market 2018-2028


Download sample pages

Complete the form below to download your free sample pages for Cell-Based Assays World Industry and Market 2018-2028


Latest Pharma news

Visiongain Publishes Biological API Manufacturing Services Market Report 2021-2031

Demand in the early years of the forecast period will come from multinational biotech looking to sign deals with Indian companies and take advantage of the cheaper costs of production for the emerging market.

08 January 2021

READ

Visiongain Publishes Anaesthesia & Respiratory Devices Market Report 2020-2030

The growth can be attributed to the rising prevalence of respiratory diseases, growing awareness for respiratory diseases, and innovations in respiratory and anesthesia devices. However, unfavourable reimbursement policies and lack of patient adherence in respiratory diseases are some of the factors restraining the growth of the anesthesia and respiratory devices market.

07 January 2021

READ

Visiongain Publishes Inactivated Vaccines Market Report 2020-2030

Factors such as rise in the prevalence of the infectious and bacterial diseases and active participation of government in vaccine development are driving the growth of this market. While high cost of vaccine development is the key factor emerging as a growth barrier over years in this market.

07 January 2021

READ

Visiongain Publishes Human Microbiome Therapeutics Market Report 2021-2031

The potential of microbiome-based drugs as novel treatments to address the unmet needs for many diseases has contributed intensively to the rapid emergence of many investors in this area. Currently, no regulatory framework exists and no drugs have received FDA approval. However, there are several preclinical and clinical-stage companies working with various approaches to develop microbiome-based therapies.

06 January 2021

READ

Categories

Category